EE
ALT icon

EWG Elevate’s Altimmune ALT Stock Holding History

EWG Elevate’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$102K – 135
2024
Q1 		$102K Sell
10,000
-5,000
-33% -$50.9K 0.04% 123
2023
Q4 		$169K Buy
15,000
+5,000
+50% +$20.9K 0.07% 100
2023
Q3 		$26K Sell
10,000
-16,000
-62% -$45.9K 0.01% 95
2023
Q2 		$91.8K Buy
+26,000
New +$117K 0.04% 97

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EWG Elevate's ALT Position: Q2 2024 in Review

EWG Elevate sold out of Altimmune (ALT) in Q2 2024, closing a stake of 10,000 shares — an estimated $102K sold.

EWG Elevate first reported a position in ALT in Q2 2023 and held it in 4 quarters. The position peaked at $169K in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • EWG Elevate reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • EWG Elevate sold 10,000 Altimmune shares in Q2 2024, an estimated $102K.
  • EWG Elevate first reported a position in Altimmune in Q2 2023 and held it in 4 quarters.
  • EWG Elevate's Altimmune position peaked at $169K in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on EWG Elevate's 13F filing for Q2 2024, filed 16 Jul 2024.